Savara SVRA
NASDAQ SVRA
$4.67 -0.09 (-1.89%)
At close: Oct 21, 2026 · 4:00 PM EDT

Savara (SVRA) Revenue (2015 - 2026)

Updated

Savara (SVRA) reported Revenue of $1,000 for Q4 2020, down 99.6% from the prior quarter.

Analysis

Savara (SVRA) Revenue (2015 - 2026) Analysis & Trends

For FY2020, Savara posted Revenue of $257,000.

  • Revenue has a five-year compound annual growth rate of 36.6% (FY2015 to FY2020).
  • By year, Revenue came in at $400,000 in FY2016 (+640.7%).
  • The Q4 2020 figure ranks as the lowest quarterly Revenue since Q2 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 25.31 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 16.99 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 15.38 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 7.80 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 15.03 Bn
10 Savara 1.19 Bn 449.49 Mn - 829,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 829,000.00
Mar 31, 2026 1.06 Mn
Dec 31, 2025 1.20 Mn
Sep 30, 2025 548,000.00
Jun 30, 2025 921,000.00
Mar 31, 2025 1.50 Mn
Dec 31, 2024 1.91 Mn
Sep 30, 2024 2.13 Mn
Dec 31, 2023 1.52 Mn
Dec 31, 2022 614,000.00
Jun 30, 2021 -558,000.00
Mar 31, 2021 -593,000.00
Dec 31, 2020 1,000.00
Sep 30, 2020 256,000.00
Jun 30, 2020 -332,000.00
Mar 31, 2020 -160,000.00
Dec 31, 2019 -86,000.00
Sep 30, 2019 5,000.00
Jun 30, 2019 31,000.00
Mar 31, 2019 -20,000.00
API Access

Savara Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=SVRA&period=max&api_key=YOUR_API_KEY